Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 December 2020 | Story Carli Kleynhans | Photo Supplied
Carli Kleynhans.

With the most gruelling year recorded in our entire lives, gradually coming to an end we remain hopeful and thankful that we have made it through. From the unexpected shock of going into lockdown, to the worry of having to use a blended approach to succeed in your academics and now finally settling into a new normal, we at the advising office bestow upon you the title of Kovsie champion…because that's exactly what you are!

One of our many champions, Carli Kleynhans, a 3rd (final) year student enrolled for BA Psychology and English shares how she survived…no, actually how she has thrived in 2020. 

• What was your biggest concern about your academics when you found out the country was going into lockdown?

My biggest concern about my academics as a final year student was whether the online learning and tests would provide the same in depth learning experiences that are necessary to build upon for future studies.

• What are some of the challenges you've experienced along the way?

Staying focused and trying not to procrastinate was a big challenge I had to conquer, especially trying to not be distracted by my family and my phone. How I survived and was able to thrive in 2020!

• What are some of the strategies you've used to ensure your academics don’t suffer? 

Time management was one of the most important strategies that I applied. For most of my classes, I was able to focus each week on a different module, by working and studying in advance I was able to keep up with my workload and still have the weekends to focus on myself, therefore creating designated time to work, study and also time to relax and read. 

• What support have you received from the institution that's helped you thus far? 
Most of my lecturers have provided needed support regarding our academics. The institution helped provide clarity with everything that was going on. 

• What do you think the UFS could have done differently to support student success? 
I think the UFS could have provided more resources for the final year students, especially considering we have to apply for further studies; online it was difficult to discern exactly what was necessary for the applications, whereas in class I feel more information would have been provided. 

• What has kept you motivated? 

Knowing it is my final year has helped to motivate me, as I have to use these grades to apply for further studies. I recently received recognition from Golden Key and this helped to further inspire me to work even harder at my academics.

• What advice do you have for your fellow Kovsies who are finding it difficult to keep going? 
Remember to make time for yourself, to look after yourself and your mental health, especially in these difficult times. Work in advance and keep to your personal academic calendar.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept